Medical devices, healthcare technology and the business of care
510(k) clearance · K261283

APERTO Lucent MRI System

Fujifilm Corporation · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK261283

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 16, 2026 for K261283, the APERTO Lucent MRI System submitted by Fujifilm Corporation under 21 CFR 892.1000, product code LNH, radiology panel. The submission is a traditional 510(k), not reviewed by a third party, and the public record shows no combination product or authorized predetermined change control plan. Clearance is not premarket approval.

The subject device is a 0.4 Tesla permanent-magnet MRI system. Its listed predicate is the APERTO Lucent MRI system cleared as K253862, and the summary states the control and image processing hardware and base software elements are identical to that predicate, with hardware comparisons reported as showing no differences. The summary references a Table 3 analysis of hardware differences, but that table is not included in the supplied excerpts, so the specific changed item and its supporting detail remain unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261283
Regulatory pathway
510(k) premarket notification
Product code
LNH
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Nuclear Magnetic Resonance Imaging.

Product code
LNH
FDA device class
2

FDA decision timeline

  1. K261283 received

    Application receipt date recorded by FDA.

  2. K261283 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LNH

Product / regulatory recordCompanyPathwayDecision dateSource
Siemens Healthineers AG510(k) clearanceNov 5, 2026FDA
Fujifilm Corporation510(k) clearanceOct 9, 2026FDA
Vista AI, Inc.510(k) clearanceOct 7, 2026FDA
Airs Medical, Inc.510(k) clearanceOct 1, 2026FDA
Aspect Imaging, Ltd.510(k) clearanceSep 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Fujifilm Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Minato-Ku

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records